Histological and Molecular Subtype of Pancreatic Cancer
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Gastrointestinal Oncology".
Deadline for manuscript submissions: closed (31 July 2025) | Viewed by 291
Special Issue Editor
Interests: pancreatic cancer; perineural invasion; pain; NGF; neutrophins
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pancreatic cancer is one of the most aggressive solid tumors and is showing increasing incidence. Its poor prognosis is mainly due to early systemic spread, local aggressiveness, and the poor efficacy of actual treatments. The most common pancreatic cancer is ductal adenocarcinoma, which accounts for more than 90% of all pancreatic malignancies. Except pancreatic adenocarcinoma, pancreatic cancer has several uncommon histological subtypes, including neuroendocrine tumors, pancreatic acinar cell carcinoma, adenosquamous carcinoma, and invasive solid pseudopapillary tumors. The clinical behavior and molecular characteristics are different among the different histological subtypes, and therefore, it can facilitate the management of different histological subtypes of pancreatic cancer. For this Special Issue, we welcome manuscripts focusing on recent advancements in the molecular or histopathological characterization of pancreatic cancer, including uncommon histological subtypes. We also welcome systematic reviews and original research on this relevant topic.
Dr. Ingrid Garajová
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- acinar cell pancreatic cancer
- adenosquamous pancreatic carcinoma
- molecular subtype
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
